Presentation
Clacido® Tablet 375 mg: Each film coated tablet contains Amoxicillin Trihydrate BP 286.95 mg equivalent to Amoxicillin 250 mg and
Clavulanate Potassium USP 148.840 mg equivalent to Clavulanic Acid 125 mg.
Clacido® Tablet 625 mg: Each film coated tablet contains Amoxicillin Trihydrate BP 573.900 mg equivalent to Amoxicillin 500 mg and
Clavulanate Potassium USP 148.840 mg equivalent to Clavulanic Acid 125 mg.
Clacido® Tablet 1g: Each film coated tablet contains Amoxicillin Trihydrate BP 1004.325 mg equivalent to Amoxicillin 875 mg and Clavulanate
Potassium USP 148.840 mg equivalent to Clavulanic Acid 125 mg.
Clacido® Powder for Suspension: Each 5 ml reconstituted suspension contains Amoxicillin Trihydrate BP 143.475 mg equivalent to
Amoxicillin 125 mg and Clavulanate Potassium USP 37.21 mg equivalent to Clavulanic Acid 31.25 mg.
Clacido® bid Powder for Suspension: Each 5 ml reconstituted suspension contains Amoxicillin Trihydrate BP 459.120 mg equivalent to
Amoxicillin 400 mg and Clavulanate Potassium USP 68.466 mg equivalent to Clavulanic Acid 57.50 mg.
Clacido® I.V. Injection 0.6 g: Each vial contains sterile Amoxicillin Sodium BP 530.10 mg equivalent to Amoxicillin 500 mg and Clavulanate
Potassium USP 119.07 mg equivalent to Clavulanic Acid 100 mg.
Clacido® I.V. Injection 1.2 g: Each vial contains sterile Amoxicillin Sodium BP 1060.20 mg equivalent to Amoxicillin 1000 mg and Clavulanate
Potassium USP 238.14 mg equivalent to Clavulanic Acid 200 mg.
Description
Clacido® is an antibacterial combination consisting of the antibiotic Amoxicillin and the Beta-lactamase inhibitor Clavulanic acid. Amoxicillin
has a broad spectrum of bactericidal activity against many gram-positive & gram-negative microorganisms but it is susceptible to degradation
by beta-lactamases and therefore the spectrum of activity does not include microorganisms, which produce these enzymes. Clavulanic acid
possesses the ability to inactivate a wide range of beta-lactamase enzymes commonly found in microorganisms resistant to penicillins and
cephalosporins. Thus Clavulanic acid in Clacido® protects Amoxicillin from degradation by beta-lactamase enzymes and effectively extends the
antibiotic spectrum to embrace a wide range of microorganisms.
Indications
Clacido® is indicated for short-term treatment of bacterial infections at the following sites:
• Upper respiratory tract infections (including ENT) e.g. recurrent tonsillitis, sinusitis, otitis media.
• Lower respiratory tract infections e.g. acute exacerbation of chronic bronchitis, lobar and bronchopneumonia.
• Genito-urinary tract infections e.g. cystitis, urethritis, pyelonephritis.
• Skin and soft tissue infections.
• Bone and joint infections e.g. osteomyelitis.
• Other infections e.g. intra-abdominal sepsis, septic abortion, puerperal sepsis, septicaemia, peritonitis, post-surgical infections.
Dosage & Administration
Tablet
Adults
The usual adult dose is one Clacido® 625 mg tablet every 12 hours or one Clacido® 375 mg tablet every 8 hours. For more severe infections
and infections of the respiratory tract, the dose should be one Clacido® 1 gm tablet every 12 hours or one Clacido® 625 mg tablet every 8
hours.
Suspension
Pediatric Patients
Neonates and Infants Aged <12 weeks (<3 months):
The recommended dose of Clacido® is 30 mg/kg/day divided every 12 hours
Clacido 625mg 6pcs
৳ 192
Description
Reviews (0)
Be the first to review “Clacido 625mg 6pcs” Cancel reply
Reviews
There are no reviews yet.